Arsenic and the skin

International Journal of Dermatology

Volumn 36, Issue 4, 1997, Pages 241-250

  Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; ARSENIC; DIMERCAPROL; RETINOID;

ENVIRONMENTAL EXPOSURE; HISTOPATHOLOGY; HUMAN; INTOXICATION; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS;

EID: 0030970670     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1997.00101.x     Document Type: Review

References (144)

1. Neubauer O. Arsenical cancer: a review. Br J Cancer 1947; 1: 192-251.
2. Carlson-Lynch H, Beck BD, Boardman PD. Arsenic risk assessment. Environ Health Perspect 1995; 102: 354-356.
3. Fishbein L. Sources, transport and alterations of metal compounds: an overview, 1. Arsenic, beryllium, cadmium, chromium, and nickel. Environ Health Perspect 1981; 40: 43-64.
4. Smith AH, Hopenhayn-Rich C, Baates MN, et al. Cancer risks from arsenic in drinking water. Environ Health Perspect 1992; 97: 259-267.
5. Vente C, Ernst K, Hundeiker M. Arsenspätschäden an der Haut. Ein aussterbendes dermatologisches Krankheitsbild. Dermatol Monatsschr 1993; 179: 375-381.
6. Engel RR, Smith AH. Arsenic in drinking water and mortality from vascular disease: an ecological study in Finland. Am J Public Health 1994; 84: 1223-1228.
7. Brown KG, Boyle KE, Chen CW, et al. A dose-response analysis of skin cancer from inorganic arsenic in drinking water. Risk Anal 1989; 9: 519-528.
8. Eisler R. A review of arsenic hazards to plants and animals with emphasis on fishery and wildlife resources. In: Nriagu JO, ed. Arsenic in the Environment. Part II: Human health and ecosystem effects. New York: John Wiley, 1994: 185-259.
9. Jackson R, Grainge JW. Arsenic and cancer. Canad Med Assoc J 1975; 113: 396-401.
10. Madorsky DD. Arsenic in dermatology. J Assoc Milit Dermatol 1977; 3(2): 19-22.
11. Sanderson KV. Arsenic and skin cancer. In: Andrade R, Gumport SL, Popkin GL, et al., eds. Cancer of the Skin-Biology-Diagnosis-Management. Philadelphia: WB Saunders, 1976: 473-491.
12. Maloney ME. Arsenic in dermatology. Dermatol Surg 1996; 22: 301-304.
13. Schwartz RA. Skin Cancer Recognition and Management. New York: Springer-Verlag, 1988: 4-56.
14. Schwartz RA, Stoll HL Jr. Epithelial precancerous lesions. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in General Medicine, 4th edn. New York: McGraw-Hill, 1993: 804-821.
15. Unna PG. Die Histopathologie der Hautkrankheiten. Berlin: Verlag von August Hirschwald, 1894: 719-724.
16. Dubreuilh W. Des hyperkeratoses circonscrites. In: Pringle JJ, ed. Third International Congress of Dermatology held in the examination hall of the conjoint Royal Colleges of Physicians and Surgeons. London, August 4th to 8th, 1896. Official Transactions. 1896. London: Waterlow and Sons, 1898: 125-176.
17. Unna PG. Über das Wesen der normalen und pathologischen Verhornung. In: Pringle JJ, ed. Third International Congress of Dermatology held in the examination ball of the conjoint Royal Colleges of Physicians and Surgeons. London, August 4th to 8th, 1896. Official Transactions. 1896. London: Waterlow and Sons, 1898: 95-118.
18. Hughes GS Jr, Davis L. Variegate porphyria and heavy metal poisoning from ingestion of 'moonshine.' South Med J 1983; 76: 1027-1029.
19. Darier J. A Text-book of Dermatology. Authorized translation from the second French edition edited with notes by S. Pollitzer. Philadephia: Lea & Febinger, 1920: 213-214, 328, 661-662.
20. Schwartz RA. Premalignant keratinocytic neoplasms. J Am Acad Dermatol 1996; 35: 223-242.
21. Schwartz RA. Treatment perspectives in actinic and other keratoses. Intern J Dermatol 1996; 35: 533-538.
22. Bloch B. Cancers and precancerous affections from the dermatological viewpoint. Cancer Rev 1932; 7: 65-98.
23. MacKee GM, Cipollaro AC. Cutaneous Cancer and Precancer. A Practical Monograph. New York: American Journal of Cancer, 1937; 4-99.
24. Montgomery H. Precancerous dermatosis and epithelioma in situ. Arch Dermatol Syphilo 1939; 39: 387-408.
25. Weiß J, Jänner M. Multiple Basaliome und Meningiom nach mehrjähriger Arsentherapie. Hautarzt 1980; 31: 654-656.
26. Grzybowski M. Histogeneza nabłoniaka w chorobie Bowena. Przegl Dermatol 1932; 17: 1-32.
27. Wick MR, Manivel JC, Millns JL. Histopathologic considerations in the management of skin cancer. In: Schwartz RA, ed. Skin Cancer Recognition and Management. New York: Springer-Verlag, 1988: 246-275.
28. Schwartz RA, Stoll HL Jr. Squamous cell carcinoma. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al., eds. Dermatology in General Medicine, 4th edn. New York: McGraw-Hill, 1993: 821-839.
29. Graham JH. Selected precancerous skin and mucocutaneous lesions. In: Neoplasms of Skin and Malignant Melanoma. Chicago: Year Book Medical Publishers, 1976: 69-121.
30. Graham JH, Helwig EB. Cutaneous premalignant lesions. In: Montagna W, Dobson RL, eds. Advances in Biology of Skin. Oxford: Pergamon Press, 1966: 277-327.
31. Crocker HR. Diseases of the Skin. Their Description, Pathology, Diagnosis, and Treatment with Special Reference to the Eruptions of Children, 2nd edn, revised and enlarged. Philadelphia: P. Blakiston & Son, 1893: 68-70, 325-327.
32. Johnson HJ. St George's Hospital. Report of some cases occurring amongst the out-patients, treated by Henry James Johnson, Esq., Senior-Assistant Surgeon. Case 1. -"Horn" growing from the scrotum - its sebaceous origin - chimney-sweeper's cancer subsequently developed. Lancet 1844; ii: 810-811.
33. Remington JP, Wood HC Jr, Sadtler SP, et al. The Dispensatory of the United States of America, 20th edn. Philadephia: JB Lippincott, 1918: 191-197, 652-654, 658-659, 1011-1012.
34. Ayres S Jr, Anderson NP. Cutaneous manifestations of arsenic poisoning. Arch Dermatol Syphilol 1934; 30: 33-43.
35. Montgomery H, Waisman M. Epithelioma attributable to arsenic. J Invest Dermatol 1941; 4: 365-380.
36. Sommers SC, McManus RG. Multiple arsenical cancers of skin and internal organs. Cancer 1953; 6: 347-359.
37. Siemens HW. General Diagnosis and Therapy of Skin Diseases. An Introduction to Dermatology for Students and Physicians. Translated from the German edition by Kurt Weiner, MD. Chicago: University of Chicago Press, 1958: 293-294.
38. Sanderson KV. Arsenic and skin cancer. Trans St John's Hospital Dermatol Soc 1963; 49: 115-122.
39. Voron DA, Tonkens SW. Arsenical keratoses. Cutis 1975; 15: 703-707.
40. Schroeder HA, Balassa JJ. Abnormal trace metals in man: arsenic. J Chronic Dis 1966; 19: 85-106.
41. Blejer HP, Wagner W. Case study 4: inorganic arsenic - ambient level approach to the control of occupational cancerigenic exposures. Ann New York Acad Sci 1976; 271: 179-186.
42. Tay C-H, Seah C-S. Arsenic poisoning from anti-asthmatic herbal preparations. Med J Austral 1975; 2: 424-428.
43. Treleaven J, Meller S, Farmer P, et al. Arsenic and ayurveda. Leukema Lymphoma 1993; 10: 343-345.
44. Cuzick J, Evans S, Gillman M, et al. Medicinal arsenic and internal malignancies. Br J Cancer 1982; 45: 904-911.
45. Reymann F, Møller R, Nielsen A. Relationship between arsenic intake and internal malignant neoplasms. Arch Dermatol 1978; 114: 378-381.
46. Diaz-Barriga F, Santos MA, Mejia JJ, et al. Arsenic and cadium exposure in children living near a smelter complex in San Luis Potosi, Mexico. Environ Res 1993; 62: 242-250.
47. Rosset M. Arsenical keratoses associated with carcinomas of the internal organs. Canad Med Assoc J 1958; 78: 416-419.
48. Southwick GJ, Schwartz RA. Arsenically associated cutaneous squamous cell carcinoma with hypercalcemia. J Surg Oncol 1979; 12: 115-118.
49. Kaposi M. Pathology and Treatment of Diseases of the Skin for Practitioner and Students. Translation of the last German edition under the supervision of James C. Johnston. New York: William Wood, 1895: 307-309.
50. Schoolmaster WL, White DR. Arsenic poisoning. South Med J 1980; 73: 198-208.
51. Edelman P. Environmental and workplace contamination in the semiconductor industry: implications for future health of the workforce and community. Environ Health Perspect 1990; 86: 291-295.
52. Sheeby JW, Jones JH. Assessment of arsenic exposure and controls in gallium arsenide production. Am Ind Hyg Assoc J 1993; 54: 61-69.
53. Park MJ, Currier M. Arsenic exposure in Mississippi: a review of cases. South Med J 1991; 84: 461-464.
54. Gidseg G. Toxic effects of marine plywood. J Am Med Assoc 1985; 253: 980-981 (letter).
55. de Peyster A, Silvers JA. Arsenic levels in hair of workers in a semiconductor fabrication facility. Am Indus Hygiene Assoc J 1995; 56: 377-383.
56. Enterline PE, Day R, Marsh GM. Cancer related to exposure to arsenic at a copper smelter. Occup Environ Med 1995; 52: 28-32.
57. Bates MN, Smith AH, Cantor KP. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 1995; 141: 513-530.
58. Sanok WJ, Ebel JG Jr, Manzell KL, et al. Residues of arsenic and lead in potato soils on Long Island. Chemosphere 1995; 30: 803-806.
59. Chiou HY, Hsueh YM, Liaw KF, et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 1995; 55: 1196-1300.
60. Hsueh YM, Cheng GS, Wu MM, et al. Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br J Cancer 1995; 71: 109-114.
61. Espinoza EO, Mann MJ, Bleasdell B, et al. Toxic metals in selected traditional Chinese medicinals. J Foren Sci 1996; 41: 453-456.
62. Das D, Chatterjee A, Mandal BK, et al. Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world. Part 2. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people. Analyst 1995; 120: 917-924.
63. Thomas DJ. Arsenic toxicity in humans: research problems and prospects. Environ Geochem Health 1994; 16: 107-111.
64. Sultzburger MB. Dermatologic Allergy. An Introduction in the Form of a Series of Lectures. London: Bailliére, Tindall & Cox, 1940: 394-395.
65. Datta DV. Arsenic in opium. Lancet 1977; i: 484 (letter).
66. Fierz U. Katamnestische Untersuchungen über die Nebenwirkungen der Therapie mit anorganischem Arsen bei Hautkrankheiten. Dermatologica (Basel) 1965; 131: 41-58.
67. White JC. Psoriais - verruca - epithelioma; a sequence. Am J Med Sci 1885; 89: 163-173.
68. Wilson E. Melasma arsenicale. J Cut Med (London) 1868; i: 354-355.
69. Hutchinson J. Arsenic cancer. Br Med J 1887; 2: 1280-1281.
70. Geyer L. Ueber die chronischen Hautveränderungen beim Arsenicismus und Betrachtungen über die Massenerkrankungen in Reichenstein in Schlesien. Arch Dermat Syph (Wien) 1898; 43: 221-280.
71. Schwartz RA. Reichenstein disease. Int J Dermatol 1991; 30: 304-305.
72. Leslie ACD, Smith H. Napoleon Bonaparte's exposure to arsenic during 1816. Arch Toxicol 1978; 41: 163-167.
73. Paddock FK, Lommis CC Jr, Perkons AK. An inquest on the death of Charles Francis Hall. N Engl J Med 1970; 282: 784-786.
74. Mees RA. Een verschijnsel bij polyneuritis arsenicosa. Nederlandsch Tijdschrift voor Geneeskunde 1919; i: 391-396.
75. Grobe J-W. Periphere Durchblutungsstörungen und Akrocyanose bei arsengeschädigten Moselwinzern. Berufs Dermatosen 1976; 24: 78-84.
76. Grobe J-W. Gutachterliche und therapeutische Befunde und Beobchtungen bei Moselwinzern mit Arsenintoxikationsspätfolgeschädigung. Berufs Dermatosen 1977; 25: 124-130.
77. Axelson O, Dahlgren E, Jansson C-D, et al. Arsenic exposure and mortality: a case-referent study from a Swedish copper smelter. Br J Industr Med 1978; 35: 8-15.
78. Nagy G, Varga G, Keresztes T, et al. Durch genuss von hoch-arsenhaltigem Wasser verursachte chronische Arsenvergiftungen. Z Hautkr 1975; 50: 101-211.
79. Tseng W-P. Blackfoot disease in Taiwan: a 30-year follow-up study. Angiology 1989; 40: 547-558.
80. Tseng W-P. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect 1977; 19: 109-119.
81. Wagner SL, Maliner JS, Morton WE, et al. Skin cancer and arsenical intoxication from well water. Arch Dermatol 1979; 115: 1205-1207.
82. Foy HM, Tarmapai S, Eamchan P, et al. Chronic arsenic poisoning from well water in a mining area in Thailand. Asia-Pacific J Public Health 1992/1993; 6: 150-152.
83. Chen C-J, Kuo T-L, Wu M-M. Arsenic and cancers. Lancet 1988; i: 414-415.
84. Yue-zhen H, Xu-chun Q, Guo-quan W, et al. Endemic chronic arsenism in Xinjiang. Chinese Med J 1985; 98: 219-222.
85. Nagy G, Németh A, Bodor F, et al. Idült arzénmérgezés által kiváltott hólyagrák esetek. Orvosi Hetilap 1980; 121: 1009-1011.
86. Feinglass EJ. Arsenic intoxication from well water in the United States. N Engl J Med 1973; 288: 828-830.
87. Tsuda T, Babazono A, Yamamoto E, et al. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol 1995; 141: 198-209.
88. Nagy G, Korom I. Späte Hautsymptome der Arsenvergiftung auf grund der Arsenendemie in Bugac-Alsómonostor. Z Hautkr 1983; 58: 961-964.
89. Simons RDGP. Aanvang, duur en beloop der arseenwerking op de nagels. Nederlandsch Tijdschrift voor Geneeskunde 1937; 81: 1913-1916.
90. Chai C-Y, Yu H-S, Yen H-T, et al. The inhibitory effect of UVB irradiation on the expression of p53 and Ki-67 proteins in arsenic-induced Bowen's disease. J Cutan Pathol 1997; 24: 8-13.
91. Graham JH, Helwig EB. Bowen's disease and its relationship to systemic cancer. AMA Arch Dermatol 1959; 80: 133-159.
92. Graham JH, Mazzanti GR, Helwig EB. Chemistry of Bowen's disease: relationship to arsenic. J Invest Dermatol 1961; 37: 317-332.
93. Shneidman D, Belizaire R. Arsenic exposure followed by the development of dermatofibrosarcoma protuberans. Cancer 1986; 58: 1585-1587.
94. Prystowsky SD, Elfenbein GJ, Lamberg SI. Nasopharyngeal carcinoma associated with long-term arsenic ingestion. Arch Dermatol 1978; 114: 602-603.
95. Miki Y, Kawatsu T, Matsuda K, et al. Cutaneous and pulmonary cancers associated with Bowen's disease. J Am Acad Dermatol 1982; 6: 26-31.
96. Zaldívar R, Prunés L, Ghai GL. Arsenic dose in patients with cutaneous carcinomata and hepatic haemangio-endothelioma after environmental and occupational exposure. Arch Toxicol 1981; 47: 145-154.
97. Lander JJ, Stanley RJ, Sumner HW, et al. Angiosarcoma of the liver associated with Fowler's solution (potassium arsenite). Gastroenterology 1975; 68: 1582-1586.
98. Falk H, Herbert JT, Edmonds L, et al. Review of four cases of childhood hepatic angiosarcoma - elevated environmental arsenic exposure in one case. Cancer 1981; 47: 382-391.
99. Kjeldsberg CR, Ward HP. Leukemia in arsenic poisoning. Ann Intern Med 1972; 77: 935-937.
100. Pershagen G. The carcinogenicity of arsenic. Environ Health Perspect 1981; 40: 93-100.
101. Petino CT, Beck BD. Evaluation of evidence of nonlinearities in the dose-response curve for arsenic carcinogenesis. Trace Sub Environ Health 1990; 24: 143-176.
102. Jung EG, Trachsel B, Immich H. Arsenic as an inhibitor of the enzymes concerned in cellular recovery (dark repair). German Medical Monthly 1969; 14: 614-616.
103. Lee T-C, Tanaka N, Lamb PW, et al. Induction of gene amplification by arsenic. Science 1988; 241: 79-81.
104. Yu H-S, Chang K-L, Wang C-M, et al. Alterations of mitogenic responses of mononuclear cells by arsenic in arsenical skin cancers. J Dermatol (Tokyo) 1992; 19: 710-714.
105. Smuckler EA. Chemicals, cancer and cancer biology. West J Med 1983; 139: 55-74.
106. Heyman A, Pfeiffer JB Jr, Willen RW, et al. Peripheral neuropathy caused by arsenical intoxication. A study of 41 cases with observations on the effects of BAL (2,3-dimercapto-propanol). N Engl J Med 1956; 254: 401-409.
107. Yeh S. Skin cancer in chronic arsenicism. Human Pathol 1973; 4: 469-485.
108. Peters HA, Croft WA, Woolson EA, et al. Seasonal arsenic exposure from burning chromium-copper-arsenate-treated wood. J Am Med Assoc 1984; 251: 2393-2396.
109. Benson AA, Summons RE. Arsenic accumulation in Great Barrier reef invertebrates. Science 1981; 211: 482-483.
110. Walkiw O, Douglas DE. Health food supplements prepared from kelp - a source of elevated urinary arsenic. Canad Med J 1974; 111: 1301-1302 (letter).
111. Quecedo E, Sanmartin O, Febrer MI, et al. Mees' lines. A clue for the diagnosis of arsenic poisoning. Arch Dermatol 1996; 132: 349-350.
112. Civantos DP, Rodriguez AL, Aquadoborruey JM, Narvaez JAJ. Fulminant malignant arrythmia and multiorgan failure in acute arsenic poisoning. Chest 1995; 108: 1774-1775.
113. Barbaud A, Moiugeolle JM, Schmutz JL. Contact hypersensitivity to arsenic in a crystal factory worker. Contact Dermatitis 1995; 33: 172-273.
114. Prasad GVR, Rossi NF. Arsenic intoxication associated with tubulointerstitial nephritis. Am J Kidney Dis 1995; 26: 373-376.
115. Cullen NM, Wolf LR, StClair D. Pediatric arsenic ingestion. Am J Emerg Med 1995; 13: 432-435.
116. Upshaw CB, Clairborne TS. Medicinal arsenic poisoning. 27-year follow-up. South Med J 1995; 88: 892-893.
117. Yu HS, Chiou KS, Chen GS, et al. Progressive alterations of cytokeratin expressions in the process of chronic arsenicism. J Dermatol (Tokyo) 1993 20: 741-745.
118. Yeh S, How SW, Lin CS. Arsenical cancer of skin. Histologic study with special reference to Bowen's disease. Cancer 1968; 21: 312-339.
119. Ohyama K, Sonoda K, Kuwahara H. Electron microscopic observations of arsenical keratosis and Bowen's disease associated with chronic arsenicism. Dermatologica (Basel) 1982; 164: 161-166.
120. Graham JH, Helwig EB. Cutaneous precancerous conditions in man. Natl Cancer Instit Monogr 1963; 10: 323-333.
121. Stout AP. Malignant manifestations of Bowen's disease. New York State Med 1939; 30: 801-809.
122. Moyer TP. Testing for arsenic. Mayo Clinic Proc 1993; 68: 121-1211.
123. Choucair AK, Ajax ET. Hair and nails in arsenical neuropathy. Ann Neurol 1988; 23: 628-629.
124. de Bértola VG, Biagini RE, Martin A, et al. Histochemical localization of arsenic in the skin of patients with regional and endemic chronic hydroarsenicism. Dermal Ibero-Latino-Amer (English edition) 1967; 11: 183-187.
125. Hsieh LL, Chen HJ, Hsieh JT, et al. Arsenic-related Bowen's disease and paraquat-related skin cancerous lesions show no detectable ras and p53 gene alterations. Cancer Letters 1994; 86: 59-65.
126. Ratnam KV, Espy MJ, Muller SA, et al. Clinicopathologic study of arsenic-induced skin lesions: no definite association with human papillomavirus. J Am Acad Dermatol 1992; 27: 120-122.
127. Rubenstein DJ, Schwartz RA, Hansen RC, et al. Punctate hyperkeratosis of the palms and soles: an ultrastructural study. J Am Acad Dermatol 1980; 3: 43-49.
128. Arhelger SW, Kremen AJ. Arsenical epitheliomas of medicinal origin. Surgery 1951; 30: 977-986.
129. Leibowitz MR, Rippey JJ, Thompson P. Fungating Bowen's disease with presumed arsenic intoxication. A case report. South Afr Med J 1982; 737-739.
130. Person JR. Bowen's disease and arsenism from tobacco smoke: an association. Cutis 1996; 58: 65-66.
131. Satterlee HS. The problem of arsenic in American cigarette tobacco. N Engl J Med 1956; 254: 1149-1154.
132. Arrighi HM, Hertzpicciotto I. Controlling the healthy worker survivor effect. An example of arsenic exposure and respiratory cancer. Occup Environ Med 1996; 53: 455-462.
133. Liu YT, Chen Z. A retrospective lung cancer mortality study of people exposed to insoluble arsenic and radon. Lung Cancer 1996; 14 (Suppl. 1): 137S-148S.
134. Hopenhaynrich C, Biggs ML, Fuchs A, et al. Bladder cancer morality associated with arsenic in drinking water in Argentina. Epidemiology 1996; 7: 117-124.
135. Thianprasit M. Chronic cutaneous arsenicism treated with aromatic retinoid. J Med Assoc Thailand 1984; 67: 93-100.
136. Rogozinski T, Geiger J-M, Czarnetzki BM, Jablonska S. Acitretin in the treatment and prevention of viral, premalignant and malignant skin lesions. J Dermatol Treat 1989; 1: 91-93.
137. Klein E. Tumors of skin. IX. Local cytostatic therapy of cutaneous and mucosal premalignant and malignant lesions. New York State J Med 1968; 68: 886-899.
138. Klein E. Tumors of the skin. X. Immunotherapy of cutaneous and mucosal neoplasms. New York State J Med 1968; 68: 900-911.
139. Klein E, Schwartz RA. Cancer and the skin. In: Holland JF, Frei III E, eds. Cancer Medicine, 2nd edn. Philadelphia: Lea & Febiger, 1982: 2057-2108.
140. Klein E, Schwartz RA, Case RW, et al. Accessible tumors. In: LoBuglio AF, ed. Clinical Immunotherapy. New York: Marcel Dekker, 1980: 31-71.
141. Jackson R, Laughlin S. Electrodesiccation and curettage. In: Schwartz RA, ed. Skin Cancer Recognition and Management. New York: Springer-Verlag, 1988: 292-295.
142. Kuflik EG. Cryosurgery updated. J Am Acad Dermatol 1994; 31: 925-944.
143. Crutcher WA. Cryosurgery of cutaneous malignancies. In: Schwartz RA, ed. Skin Cancer Recognition and Management. New York: Springer-Verlag, 1988: 299-310.
144. Szeimies R-M, Karrer S, Heine A, et al. Arsenic-induced skin tumors treated with topical photodynamic therapy after application of 5-aminolevulinic acid. Eur J Dermatol 1995; 5: 208-211.